Literature DB >> 21649681

Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults.

Guldane Koturoglu1, Zafer Kurugol, Ebru Turkoglu.   

Abstract

This study aimed to assess the age specific varicella-zoster virus (VZV) seroprevalence in Izmir, Turkey and to determine the reliability of a history of varicella to detect susceptible children, adolescents and adults. A questionnaire, including previous history of varicella, was completed for each participant and, in 590 of them, VZV-specific IgG was measured using an ELISA test. Overall, 28.5% of individuals were seronegative for VZV. By 5 years of age, only 25.5% of children were seropositive for VZV. Among adolescents and young adults, 18.8% and 11.7% were seronegative, respectively. The negative predictive value was 57.8%, decreasing with age (81.9% in children, 34.5% in adolescents and 8.3% in adults). In conclusion, a negative history of varicella is not a reliable predictor of varicella antibody status in adolescents and young adults. Serological testing before immunisation will be logical, rather than presumptive vaccination, for adolescents and adults with negative history of varicella.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21649681     DOI: 10.1111/j.1365-3016.2010.01180.x

Source DB:  PubMed          Journal:  Paediatr Perinat Epidemiol        ISSN: 0269-5022            Impact factor:   3.980


  8 in total

1.  The epidemiology and economic impact of varicella-related hospitalizations in Turkey from 2008 to 2010: a nationwide survey during the pre-vaccine era (VARICOMP study).

Authors:  Ener Cagri Dinleyici; Zafer Kurugol; Ozden Turel; Nevin Hatipoglu; Ilker Devrim; Hasan Agin; Ilker Gunay; Olcay Yasa; Muferet Erguven; Nuri Bayram; Ali Kizildemir; Emre Alhan; Emine Kocabas; Hasan Tezer; H Hakan Aykan; Nazan Dalgic; Betul Kilic; Gulnar Sensoy; Nursen Belet; Nihan Uygur Kulcu; Aysu Say; Mehmet Ali Tas; Ergin Ciftci; Erdal Ince; Halil Ozdemir; Melike Emiroglu; Dursun Odabas; Zeynel Abidin Yargic; Cagatay Nuhoglu; Kursat Bora Carman; Solmaz Celebi; Mustafa Hacimustafaoglu; Murat Elevli; Zahide Ekici; Umit Celik; Meda Kondolot; Mustafa Ozturk; Anil Tapisiz; Metehan Ozen; Harun Tepeli; Aslinur Parlakay; Ates Kara; Ayper Somer; Bahar Caliskan; Sevtap Velipasalioglu; Selim Oncel; Emin Sami Arisoy; Ekrem Guler; Tahir Dalkiran; Denizmen Aygun; Saadet Akarsu
Journal:  Eur J Pediatr       Date:  2011-12-16       Impact factor: 3.183

2.  Varicella immunity in Iran: an age-stratified systematic review and meta-analysis.

Authors:  Abbas Allami; Navid Mohammadi
Journal:  Iran J Microbiol       Date:  2014-12

Review 3.  Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs.

Authors:  Peter A C Maple
Journal:  Vaccines (Basel)       Date:  2015-12-09

4.  Seroprevalence of Varicella zoster virus antibody among young women before marriage in Sanandaj, Iran.

Authors:  Parviz Majidy; Mazaher Khodabandehloo; Nammam-Ali Azadi
Journal:  Iran J Microbiol       Date:  2016-04

5.  Seroprevalence and Risk Factors of Varicella Zoster Infection in Iranian Adolescents: A Multilevel Analysis; The CASPIAN-III Study.

Authors:  Shervin Ghaffari Hoseini; Roya Kelishadi; Amir Kasaeian; Behrooz Ataei; Majid Yaran; Mohammad Esmaeil Motlagh; Ramin Heshmat; Gelayol Ardalan; Omid Safari; Mostafa Qorbani; Seyed Naseredin Mostafavi
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

Review 6.  Varicella infection in the Middle East: Prevalence, complications, and vaccination.

Authors:  Mariam Al-Turab; Wassim Chehadeh
Journal:  J Res Med Sci       Date:  2018-04-26       Impact factor: 1.852

7.  Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model.

Authors:  Lara J Wolfson; Vincent J Daniels; Matthew Pillsbury; Zafer Kurugöl; Cuneyt Yardimci; Jeffrey Kyle; Ener Cagri Dinleyici
Journal:  PLoS One       Date:  2019-08-13       Impact factor: 3.240

8.  Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England.

Authors:  Nigel Field; Gayatri Amirthalingam; Pauline Waight; Nick Andrews; Shamez N Ladhani; Albert Jan van Hoek; Peter A C Maple; Kevin E Brown; Elizabeth Miller
Journal:  Vaccine       Date:  2013-07-16       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.